The free evaluation of evidence of prior use (T 0042/19)
The IPKat
MAY 15, 2023
The Patentee argued that the GensuPen had only been given out as part of a trial under conditions of confidentiality ( Cf. The Board of Appeal agreed with the OD that the prior use had not been sufficiently proven. Ms Simon testified that, prior to the priority date, she had received a GensuPen injection device.
Let's personalize your content